Fifth Third Bancorp »

Pliant Therapeutics shares owned by Fifth Third Bancorp

Quarter-by-quarter ownership of Pliant Therapeutics (PLRX) shares owned by Fifth Third Bancorp from 13F filings

Historical chart of Fifth Third Bancorp investment in Pliant Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Pliant Therapeutics held by Fifth Third Bancorp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pliant Therapeutics by Fifth Third Bancorp

Quarter filed Position value Share count Share price at filing
2026-03-31 $5 4 1.25

More positions owned by Fifth Third Bancorp

NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Eli Lilly & Co. (LLY)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Ishares Tr S&p 100 Etf (OEF)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Exxon Mobil Corporation (XOM)
Ishares Tr Core S&p Mcp Etf (IJH)

View all positions for Fifth Third Bancorp

Top funds holding Pliant Therapeutics

Tang Capital Management
Citadel Advisors
Blue Owl Capital Holdings
Vanguard Group
ADAR1 Capital Management
Acadian Asset Management
Vanguard Capital Management
Two Sigma Investments
Monaco Asset Management SAM
Woodline Partners
Prosight Management
BML Capital Management
Peapod Lane Capital
Millennium Management
BlackRock

View all funds holding Pliant Therapeutics